You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High risk node negative breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Oslo (Docetaxel)

Completed
  • Breast Cancer
  • Oslo, Norway
    RRHF
Apr 21, 2022

Breastcancer Trial in India (Post Mastectomy Radiation therapy)

Recruiting
  • Breastcancer
  • Post Mastectomy Radiation therapy
  • New Delhi, Delhi, India
  • +6 more
Jul 4, 2022

Breast Cancer Trial in India (Carboplatin, Cyclophosphamide, Docetaxel)

Completed
  • Breast Cancer
  • Hyderabad, Andhra Pradesh, India
  • +5 more
Aug 5, 2021

Breast Cancer Trial in Shanghai (Regional lymph node radiotherapy, chest/whole breast irradiation)

Recruiting
  • Breast Cancer
  • Regional lymph node radiotherapy
  • chest/whole breast irradiation
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Aug 3, 2023

Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast Cancer Trial

Enrolling by invitation
  • Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stageļ¼ŒFemale Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 20, 2021

Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Cryoablation
  • Cryoablation combined with PD1 Inhibitor
  • (no location specified)
Mar 28, 2023

Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Oct 5, 2023

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Breast Cancer Trial in Ann Arbor (Ribociclib, Postoperative Radiation Therapy)

Not yet recruiting
  • Breast Cancer
  • Ann Arbor, Michigan
    University of Michigan
Aug 10, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Radiation OmisSion in PAtients With CLinically Node Negative

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    May 10, 2023

    Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • Ovarian function suppression with endocrine treatments
    • Seoul, Korea, Korea, Republic of
      Gangnam Severance Hospital
    Dec 18, 2022

    Breast Cancer, Clinically Assessed Negative Axillary Lymph Nodes, Sentinel Lymph Node Trial in Nanjing (Omit SLNB)

    Recruiting
    • Breast Cancer
    • +2 more
    • Omit SLNB
    • Nanjing, Jiangsu, China
      the First Affiliated Hospital of Nanjing Medical University
    Jul 4, 2023

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Sentinel Lymph Node Biopsy (SLNB)
    • +7 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jul 31, 2023

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Surgery for harvesting tumor-draining lymph nodes
    • +6 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Nov 2, 2023

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Surgery for harvesting tumor-draining lymph nodes
    • +8 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jul 31, 2023

    Breast Cancer Trial in Gothenburg, Lund (De-escalation)

    Not yet recruiting
    • Breast Cancer
    • De-escalation
    • Gothenburg, Sweden
    • +1 more
    Nov 29, 2022

    Frequency of Occult Breast Cancer After Prophylactic Mastectomy

    Recruiting
    • Genetic Predisposition
    • +3 more
    • Histopathological confirmation
    • Karachi, Sindh, Pakistan
      Aga Khan University Hospital
    Mar 15, 2023

    Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

    Completed
    • Breast Neoplasms
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Oct 26, 2022

    Breast Cancer Trial (Pyrotinib, Trastuzumab, Paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Apr 22, 2023

    Breast, Metastatic, Triple Negative Trial in Gainesville, Jacksonville (Capecitabine, Sarilumab 150mg or 200 mg plus

    Active, not recruiting
    • Breast
    • +4 more
    • Gainesville, Florida
    • +1 more
    Feb 2, 2023

    Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph

    Recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Radiation Therapy Boost
    • +6 more
    • Washington, District of Columbia
    • +8 more
    Dec 5, 2022

    Breast Cancer Trial in Montpellier (Treatment ETHOS radiotherapy, Conventional IMRT)

    Not yet recruiting
    • Breast Cancer
    • Treatment ETHOS radiotherapy
    • Conventional IMRT
    • Montpellier, France
      Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
    Sep 19, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    LYNPARZA Breast Cancer in Adjuvant Setting Japan Post-Marketing

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Jan 9, 2023